Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06205121 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06205121 · ClinicalTrials.gov record · last posted 2026-07-30

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Name: Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis — clinical trial record (NCT06205121)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorMolecure S.A.

Started2024-03-21

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01 in the treatment of subjects with active pulmonary sarcoidosis.

Amendment record 8 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 8 times since 2024-01-03; most recent amendment 2025-12-05. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-03-01

Status change Not Yet Recruiting→Recruitingv1

Trial Details

NCT Number	NCT06205121
Lead Sponsor	Molecure S.A.
Conditions	Pulmonary Sarcoidosis
Enrollment	96 participants
Start Date	2024-03-21
Primary Completion	2027-08 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-30